Company Description
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.
The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
| Country | United Kingdom |
| Founded | 2022 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 24,561 |
| CEO | Brian McNamara |
Contact Details
Address: The Heights, Building 5, First Floor Weybridge, KT13 0NY United Kingdom | |
| Phone | 44 1932 959 500 |
| Website | haleon.com |
Stock Details
| Ticker Symbol | HLN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| CIK Code | 0001900304 |
| CUSIP Number | 405552100 |
| ISIN Number | US4055521003 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Brian James McNamara | Chief Executive Officer and Executive Director |
| Dawn Amanda Allen | Chief Financial Officer and Director |
| Claire Dickson | Chief Digital and Technology Officer |
| Adrian Charles Morris | General Counsel |
| Tamara Rogers | Chief Marketing Officer |
| Line De Decker | Chief Human Resources Officer |
| Filippo Lanzi | President of EMEA and LatAm |
| Keith Choy | President of Asia Pacific |
| Lisa Paley | President of North America |
| Franck Riot | Chief Research & Development Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 28, 2025 | 6-K | Report of foreign issuer |
| Mar 24, 2025 | SCHEDULE 13D/A | Filing |
| Mar 24, 2025 | 25-NSE | Filing |
| Mar 21, 2025 | 6-K | Report of foreign issuer |
| Mar 21, 2025 | 6-K | Report of foreign issuer |
| Mar 21, 2025 | 6-K | Report of foreign issuer |
| Mar 21, 2025 | 6-K | Report of foreign issuer |
| Mar 21, 2025 | 6-K | Report of foreign issuer |
| Mar 20, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Mar 20, 2025 | 6-K | Report of foreign issuer |